Company: HQL
Filing Date: 2025-12-08
Form Type: N-CSR
Source: 0001104659-25-119341
Chunk: 71

Company: abrdn Life Sciences Investors
Filing Date: 2025-12-08
Form: N-CSR
Chunk 71
---
 where he had served as Vice President of Closed-End Fund Product Strategy since November 2013. |
| Loretta Tse**                 
 c/o abrdn Inc.                
 28 State Street               
 17th floor                    
 Boston, MA 02109              
 Year of Birth: 1967           | Vice President                         | Since 2023      | Currently Investment Director at abrdn. Ms. Tse joined abrdn in October 2023 from Tekla Capital Management LLC where she was a Vice President investing in venture.                                               
 Previously, she worked for the Fred Hutchinson Cancer Research Center and Oxford Biosciences Partners.                                                                                                            |
| Ashton Wilson**               
 c\o abrdn Inc.                
 1900 Market Street            
 Suite 200                     
 Philadelphia, PA 19103        
 Year of Birth: 1986           | Vice President                         | Since 2024      | Currently Senior Investment Director in healthcare portfolio management. Mr. Wilson joined abrdn in October 2023 from Tekla Capital Management                                                                    
 where he was a Senior Vice President. Previously, he worked for Goldman Sachs and Co.                                                                                                                             |

| *  | Officers hold their positions with the Fund until a successor has been duly elected and qualifies. Officers are elected annually at a meeting of the Fund Board. |
| ** | Each officer may hold officer position(s) in one or more other funds which are part of the Fund Complex.                                                         |

Further information about the Fund's Board Members and Officers is available in the Fund's Statement of Additional Information, which can be obtained without charge by calling (800) 522-5465.

| abrdn Life Sciences Investors | 57 |

<div align='center'>[THIS PAGE INTENTIONALLY LEFT BLANK]

[THIS PAGE INTENTIONALLY LEFT BLANK]

[THIS PAGE INTENTIONALLY LEFT BLANK]</div>

#### Corporate Information
Trustees Todd Reit, ChairJeffrey Bailey
Rose DiMartino
Kathleen Goetz
C. William Maher
Christian Pittard Investment Adviser abrdn Inc.
1900 Market Street, Suite 200
Philadelphia, PA 19103 Custodian State Street Bank and Trust Company
John Adams Building
1776 Heritage Drive
North Quincy, MA 02171 Transfer Agent Computershare Trust Company, N.A.
P.O. Box 43006
Providence, RI 02940-3078

#### Independent Registered Public Accounting Firm
KPMG LLP 
 191 West Nationwide Blvd., Suite 500